Logo image
Analogues of the anti-malaria drug mefloquine have broad spectrum antifungal activity and are efficacious in a model of disseminated Candida auris infection
Preprint   Open access

Analogues of the anti-malaria drug mefloquine have broad spectrum antifungal activity and are efficacious in a model of disseminated Candida auris infection

Soumitra Guin, Marhiah C. Montoya, Xiaoyu Wang, Robert Zarnowski, David R. Andes, Marvin J. Meyers, Noelle S. Williams and Damian J. Krysan
bioRxiv
Cold Spring Harbor Laboratory
08/30/2024
DOI: 10.1101/2024.08.29.610379
PMCID: PMC11383691
PMID: 39257751
url
https://doi.org/10.1101/2024.08.29.610379View
Preprint (Author's original)This preprint has not been evaluated by subject experts through peer review. Preprints may undergo extensive changes and/or become peer-reviewed journal articles. Open Access

Abstract

Only three classes of antifungal drugs are currently in clinical use. Here, we report that derivatives of the malarial drug mefloquine have broad spectrum antifungal activity including difficult to treat molds and endemic fungi. Pharmacokinetic and efficacy studies of NSC-4377 indicate it penetrates the central nervous system and is active against Candida auris in vivo. These data strongly support the further development of mefloquine analogs as a potentially new class of antifungal molecules.

Details

Metrics

16 Record Views
Logo image